Author(s): Suresh Kumar, Nirma Chavda

Email(s): jdrsuresh@gmail.com

DOI: 10.52711/2231-5675.2023.00032   

Address: Suresh Kumar1*, Nirma Chavda2 1B. Pharmacy College Rampura, Kakanpur, Gujarat.
2Research Scholar, Gujarat Technological University, Ahmedabad.
*Corresponding Author

Published In:   Volume - 13,      Issue - 3,     Year - 2023


ABSTRACT:
Hypertension is a popular disease that is specified by having a lot of quantity of pressure in blood vessels than normal. High blood pressure is a very general disorder, especially past middle age. It is a vital risk issue for cardiovascular mortality. For enhanced activity of hypertension, Rosuvastatin and Fimasartan are newer combination in the market, which is effective in High blood pressure. This combination was developed to enhance medication for Stage II Hypertension. This article gives information about totally different analytical method development like spectrophotometric and chromatographic methods reported for Rosuvastatin and Fimasartan for individual and other drug combinations. All reported methods were found to be simple, accurate, economic, precise and reproducible in nature. This Review delivers on latest development in analytical method development for Rosuvastatin and Fimasartan, and there are no methods reported for this combination as per our knowledge.


Cite this article:
Suresh Kumar, Nirma Chavda. A Review on Analytical Method Development and Validation for the Simultaneous Estimation of Rosuvastatin and Fimasartan in Bulk and its Pharmaceuticle Dosage Form. Asian Journal of Pharmaceutical Analysis. 2023; 13(3):197-4. doi: 10.52711/2231-5675.2023.00032

Cite(Electronic):
Suresh Kumar, Nirma Chavda. A Review on Analytical Method Development and Validation for the Simultaneous Estimation of Rosuvastatin and Fimasartan in Bulk and its Pharmaceuticle Dosage Form. Asian Journal of Pharmaceutical Analysis. 2023; 13(3):197-4. doi: 10.52711/2231-5675.2023.00032   Available on: https://ajpaonline.com/AbstractView.aspx?PID=2023-13-3-8


REFERENCES:
1.    https://www.drugbank. ca/drugs/DB01098. Accessed 10 July2019. (Drug Bank (2019) Rosuvastatin Calcium).
2.    https:// www.drugbank.ca/drugs/DB09279. Accessed 9 July 2019 (Drug Bank (2019) Fimasartan potassium trihydrate).
3.    Kansara, D.A, Chhalotiya, U.K, Kachhiya, H.M. Simultaneous estimation of amlodipine besylate, Rosuvastatin calcium and Fimasartan potassium trihydrate combination used in the treatment of hypertension using LC method. SN Appl. Sci. 2.
4.    Charu P. Pandya1 and Sadhana J. Rajput. Separation and characterization of major oxidative impurity in fimasartan drug substance. Rasayan J. Chem. 2018; 11(3): 1042-1049 http://dx.doi.org/10.31788/RJC.2018.1132083.
5.    M. Girija, N. Kokilavani. Effectiveness of Structured Teaching Programme on Knowledge, Attitude and Practice among Patients with Hypertension. Asian J. Nur. Edu. and Research. 2014; 4(1): 136-139.
6.    Devi. S, L N Samaga. Effect of transcendental meditation on stress and blood pressure among patients with systemic hypertension. Asian J. Nur. Edu. and Research. 2015; 5(1): 151-156.
7.    Suraj V. Bondre, Rushikesh S. Chavan, Indrayani D. Raut, Shrinivas K. Mohite, Chandrakant S. Magdum. An Overview of Survey on Antihypertensive Drugs. Asian J. Pharm. Res. 2020; 10(3):160-162.
8.    V.V. Karkhanis, Vikas Parikh, Roma Panchal. Estimation of Rosuvastatin Calcium in Tablet Dosage Form by HPTLC Method. Asian J. Research Chem. 2011; 4(8): 1206-1209.
9.    ICH harmonized tripartite guideline: Stability testing of new drug substances and products, Q1A(R2). International Conference on Harmonization, Geneva. 2003:1-24.
10.    https://go.drugbank.com/drugs/DB09279.
11.    ICHQ2(R1): Validation of Analytical Procedure. Text and Methodology. International Conference on Harmonization. IFPMA. Geneva, Switzerland, 2005.
12.    Nirma Chavda, Suresh Kumar. A Review article on Analytical Method Development for the combination of Azelnidipine and Telmisartan. Asian Journal of Pharmaceutical Analysis. 2021; 11(3):227-4.
13.    Hamid Khan. Analytical Method Development in Pharmaceutical Research: Steps involved in HPLC Method Development. Asian J. Pharm. Res. 2017; 7(3): 203-207.
14.    Chinmaya Keshari Sahoo, Muvvala Sudhakar, D. Venkata Ramana, K. Satyanarayana, Kanhu Charan Panda. Validation of Analytical Procedures- A Review. Asian J. Pharm. Ana. 2018; 8(2): 109-116.
15.    Praful Sahare, Amit Nayak, Alok Pal Jain, Harikishor Barange. Development of Validated Analytical Methods and Stability Indicating studies for Pharmaceutical Formulation. Asian J. Pharm. Ana. 2021; 11(1):29-37.
16.    https://pubchem.ncbi.nlm.nih.gov/compound/Rosuvastatin. National Center for Biotechnology Information (2022). PubChem Compound Summary for CID 446157, Rosuvastatin. Retrieved September 5, 2022.
17.    https://pubchem.ncbi.nlm.nih.gov/compound/Fimasartan. National Center for Biotechnology Information (2022). PubChem Compound Summary for CID 9870652, Fimasartan. Retrieved September 5, 2022 from
18.    https://go.drugbank.com/drugs/DB01098.
19.    Rang, H. P, Dale, M. M. (2012). Rang and Dale's Pharmacology (7th ed.), Edinburgh: Elsevier/Churchill Livingstone. (ISBN 978-0-7020-3471-8).
20.    Kim JH, Lee JH, Paik SH, Kim JH, Chi YH. Fimasartan, a novel angiotensin II receptor antagonist. Arch Pharm Res. 2012 Jul;35(7):1123-6. doi: 10.1007/s12272-012-0700-z. (PubMed ID 22864732).
21.    Agrawal KS, Gandhi LR, Bhajipale NS. UV Spectrophotometric Method Development and Validation of Fimasartan Drug and Its Tablet Formulation. Asian Journal of Pharmaceutical Research and Development. 2019; 7(5): 26-30.
22.    Sruthi a, uttam prasad panigrahy. Stability indicating method development and validation of fimasartan by reverse-phase high-performance liquid chromatography in bulk and pharmaceutical dosage form. Asian J Pharm Clin Res. 2021; 14(2): 138-14.
23.    Seo Hyun Yoon, Seul Oh, Hwa Suk Kim, SoJeong Yi, Kyung-Sang Yu, In-Jin Jang, Joo-Youn Cho. Validated LC–MS/MS Assay for the Quantitative Determination of Fimasartan in Human Plasma: Application to Pharmacokinetic Studies. Journal of Chromatographic Science. 2015; 53(8): 1250–1256. https://doi.org/10.1093/chromsci/bmu219
24.    Radhika G. Sojitra, Urvi J. Chotaliya. Analytical method development and validation for simultaneous estimation of Fimasartan Potassium Trihydrate and Cilnidipine in synthetic mixture by HPLC for the treatment of hypertension stage-II. Futur J Pharm Sci. 2021; 7:189.
25.    Hyeon Woo Moon, Abid Mehmood Yousaf, Kwan Hyung Cho, Chul Soon Yong, Jong Oh Kim, Han-Gon Choi. Evaluation of stability and simultaneous determination of fimasartan and amlodipine by a HPLC method in combination tablets. Asian Journal of Pharmaceutical Sciences. 2014; 9(3):123-128.
26.    Kritika Rai1 and Dr. Nutan Rao. Development and validation of novel rp- hplc method for related substances in chlorthalidone and fimasartan formulations. World Journal of Pharmaceutical Research. 2020; 9(4).
27.    Do-Hyung Kim, Jeong-Hun Lee, Wang-seob Shim and Kyung-Tae Lee. Development and validation of a high-performance liquid chromatography-tandem-tandem mass spectrometry for quantitative determination of Fimasartan and Amlodipine in human plasma: Its application to a pharmacokinetic study. Journal of Pharmaceutical Care and Health System.  
28.    Devansh Kansara, Usmangani K. Chhalotiya, Hetaben M. Kachhiya and Ishita Patel. Development of TLC method for simultaneous estimation of novel combination of amlodipine besylate, rosuvastatin calcium, and fimasartan potassium in synthetic mixture. J. Chem. Metrol. 2020; 14.
29.    Giri P, Joshi V, Giri S, Delvadia P, Jain MR. Simultaneous determination of sacubitrilat and fimasartan in rat plasma by a triple quad liquid chromatography-tandem mass spectrometry method utilizing electrospray ionization in positive mode. Biomed Chromatography. 2021; 35(2): e4981. doi: 10.1002/bmc.4981. Epub 2020 Sep 18. PMID: 32895916.
30.    Indian Pharmacopeia 2010. Indian Government Health and Welfare Society. Ghaziabad. 2072-2073.
31.    Trivedi HK, Patel MC. Development and Validation of a Stability-Indicating RP-UPLC Method for Determination of Rosuvastatin and Related Substances in Pharmaceutical Dosage Form. Sci Pharm. 2012; 80(2): 393-406. doi: 10.3797/scipharm.1201-09. Epub 2012 Mar 26. PMID: 22896825; PMCID: PMC3383219.
32.    Kaila HO, Ambasana MA, Thakkar RS, Saravaia HT, Shah AK. A New Improved RP-HPLC Method for Assay of Rosuvastatin Calcium in Tablets. Indian J Pharm Sci. 2010; 72(5): 592-8. doi: 10.4103/0250-474X.78526. PMID: 21694991; PMCID: PMC3116304.
33.    Sailaja B, Sravana Kumari K. Stability-indicating method development and validation for the estimation of rosuvastatin calcium in bulk and tablet formulation by reverse-phase high-performance liquid chromatography. Asian J Pharm Clin Res. 2019; 12(8): 251-256.
34.    Nazrul Haq, Faiyaz Shakeel, Fars Alanazi, Doaa H. Alshora and Mohamed Abbas Ibrahim. Development and validation of a green RP-HPLC method for the analysis of rosuvastatin: a step towards making liquid chromatography environmentally benign. Green Process Synth. 2018; 7: 160–169.
35.    Dipak R Supe, Padmanabh B. Deshpande, Saurabh Jadhav and Sandeep Swami. Stability indicating high performance thin layer chromatography method development and validation for estimation of rosuvastatin calcium as bulk drug and in tablet dosage form. European Journal of Biomedical and Pharmaceutical Sciences. 2021; 8(9).
36.    Prabhu Venkatesh Moodbidri, Varadaraji Dhayanithi, Ganesh Belavadi Manjunathashastry, Hari Narayan Pati, Pardhasaradhi Vasireddy. A New Simultaneous Determination of Rosuvastatin Calcium and its Lactone Impurity by Reverse Phase HPLC method. Asian J. Pharm. Res. 2015; 5(4): 175-182.
37.    Padmavathi, R, Padmavathi, Y, Babu, N, Akhila, V, and Keerthi, G. Development and Validation of Difference Spectrophotometric Method for Simultaneous Estimation of Rosuvastatin Calcium and Aspirin in Marketed Formulation. Asian Journal of Pharmaceutical Research and Development. 2021; 9(6): 56-61. https://doi.org/https://doi.org/10.22270/ajprd.v9i6.1046.
38.    Vyas, A, Godhaniya, J, Patel, A, Patel, A, Patel, N, Shah, S and Sheth, D. (2021). Development and Validation of UV-Spectroscopic First Order Derivative Method for Simultaneous Estimation of Rosuvastatin Calcium and Teneligliptin Hydrobromide Hydrate in Synthetic Mixture. Chemical Methodologies. 2021; 5(4): 317-323. doi: 10.22034/chemm.2021.131260.
39.    Sireesha. D, M. Laksmi Monika, Vasudha Bakshi. Development and Validation of UV Spectrophotometric Method for The Simultaneous Estimation of Rosuvastatin and Ezetimibe in Pharmaceutical Dosage Form. Asian J. Pharm. Ana. 2017; 7(3): 135-140. doi: 10.5958/2231-5675.2017.00021.7.
40.    Namdeo G. Shinde and Nagesh H. Aloorkar. Development and validation of UV spectrophotometric method for simultaneous estimation of propranolol hydrochloride and rosuvastatin calcium in bulk drug and pharmaceutical dosage form. International Journal of Advances in Pharmaceutics. 2015; 4(5) DOI: 10.7439/ijap.
41.    Bhavna Patel, Alpa Jadav, Heena Solanki, Shraddha Parmar, Vijay Parmar, Anadikumari Captain. Development and Validation of Derivative Spectroscopic Method for the Simultaneous Estimation of Rosuvastatin Calcium and Fenofibrate in Tablet. International Journal of Pharma Research and Review. 2013; 2(7):1-6.
42.    Afroz Asma, Haque Tasnuva, Md. Talukder Mesbah Uddin, Islam S. M. Ashrafu, Spectrophotometric Estimation of Rosuvastatin Calcium and Glimepiride in Tablet Dosage Form. Asian Journal of Pharmaceutical Analysis. 2011; 1(4): 74-78.
43.    Roshan Telrandhe. Development and Validation of UV Spectrophotometry and RP-HPLC Method for simultaneous determination of Rosuvastin and Clopidogrel in Tablet Dosage Form. Asian J. Pharm. Ana. 2018; 8(1): 25-32.
44.    Gholve, R, Pekamwar, S, Wadher, S. Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form. Futur J Pharm Sci. 2021; 7: 224. https://doi.org/10.1186/s43094-021-00369-2
45.    Rajeswar Dutt, Kunduri. RP_HPLC method development and validation for the simultaneous estimation of Rosuvastatin and Ezetimibe in tablet dosage form. International Journal of Pharmacy and Analytical Research. 2014; 3: 13-21.
46.    Tiwari, Pradip and Jain, Amit and Dubey, BK and Pandey, GK and Dhakad, Suresh.  Analytical Method Development and Validation for the Simultaneous Estimation of Aspirin, Clopidogrel and Rosuvastatin in Pharmaceutical Dosage Form. Journal of Drug Delivery and Therapeutics. 2019; 9: 432-438. 10.22270/jddt.v9i4-s.3351.
47.    M. Sumalatha, K. Haritha Pavani. Analytical method development and validation for the simultaneous estimation of Rosuvastatin and Finofibate in tablet dosage form by reverse phase high performance liquid chromatography. Indian Journal of Research in Pharmacy and Biotechnology.
48.    D. Sangeetha and M. K. Vadlamudi. Development and Validation of a Stability-indicating RP-HPLC Method for Estimation of Metformin and Rosuvastatin along with Impurities from a Combined Oral Solid Dosage Form. Indian J Pharm Sci. 2019; 81(2): 365-372. DOI: 10.36468/pharmaceutical-sciences.518.
49.    Min Nyeong Choi, Y. J. Park and Joo Eun Ki. Development and Validation of a Reversed-phase High Performance Liquid Chromatography Method for the Simultaneous Estimation of Rosuvastatin Calcium and Telmisartan in Fixed-Dose Complex Dual-Layer Tablets in Six Dosage Forms. Indian J Pharm Sci. 2021; 83(3): 451-464, DOI: 10.36468/pharmaceutical-sciences.794.
50.    Dipali Tajane, Amol M. Raurale, Pradeep D. Bharande, Anil N. Mali, Amol V. Gadkari, Vishal R. Bhosale. Development and validation of a RP-HPLC-PDA method for simultaneous determination of Rosuvastatin calcium and Amlodipine besylate in pharmaceutical dosage form. Journal of Chemical and Pharmaceutical Research. 2012; 4(5): 2789-2794.
51.    Padmavathi, R, Padmavathi, Y, Babu, N, Akhila, V, and Keerthi, G. Development and Validation of Difference Spectrophotometric Method for Simultaneous Estimation of Rosuvastatin Calcium and Aspirin in Marketed Formulation. Asian Journal of Pharmaceutical Research and Development. 2021; 9(6): 56-61. https://doi.org/https://doi.org/10.22270/ajprd.v9i6.1046.
52.    Drashti A. Mandale, Chainesh Shah, Rakesh Jatt. Development and validation of novel RP-HPLC method for the simultaneous determination of Rosuvastatin and Teneligliptin in bulk and in synthetic mixture. International Journal of Pharmaceutical Research.
53.    Dipak R Supe, Padmanabh B. Deshpande, Saurabh Jadhav and Sandeep Swami. Stability indicating high performance thin layer chromatography method development and validation for estimation of rosuvastatin calcium as bulk drug and in tablet dosage form. European Journal of Biomedical and Pharmaceutical Sciences.  2021; 8(9).
54.    Vyas, A, Godhaniya, J., Patel, A, Patel, A, Patel, N, Shah, S and Sheth, D. Development and Validation of UV-Spectroscopic First Order Derivative Method for Simultaneous Estimation of Rosuvastatin Calcium and Teneligliptin Hydrobromide Hydrate in Synthetic Mixture. Chemical Methodologies. 2021; 5(4): 317-323. doi: 10.22034/chemm.2021.131260.
55.    Pallavi H. Tank, K. R. Vadalia, Z. R. Dedania. Development and validation of hptlc method for simultaneous estimation of rosuvastatin calcium and aspirin in capsule dosage form. Tank et al. IJPSR. 2012; 3(10): 3867-3870.
56.    Rujuta P. Mistry, Chainesh Shah, Rakesh Jat. RP-HPLC Method Development and Validation for Simultaneous Estimation of Telmisartan, Rosuvastatin Calcium and Amlodipine Besylate in Combination. Folia Medica. 2022; 64(1):103-9 DOI: 10.3897/folmed.64.e64339.
57.    R. Dastaran, A. Sheibani, M. Reza Shishehbore, H. Saeedi-Sourck. Continuous Wavelet Transform for Simultaneous Determination of Atorvastatin and Rosuvastatin in Combined Pharmaceutical Formulations. Journal of Applied Spectroscopy. 2022; 88(6): 1195-1201. 10.1007/s10812-022-01299-4 .
58.    Najma Sultana, M. Saeed Arayne, Shabana Naz Shah, Nighat Shafi, Safila Naveed. Simultaneous Determination of Prazosin, Atorvastatin, Rosuvastatin and Simvastatin in API, Dosage Formulations and Human Serum by RP-HPLC. Journal of the Chinese Chemistry Society. 2010; 57(6): 1286-1292.

Recomonded Articles:

Author(s): Pankaj Bhamare, Rupal Dubey, Neeraj Upmanyu, Pothuvan Umadoss

DOI: 10.5958/2231-5675.2021.00001.6         Access: Open Access Read More

Author(s): Hamid Khan, Javed Ali

DOI: 10.5958/2231-5675.2017.00020.5         Access: Open Access Read More

Author(s): K. Pramod, Shahid H. Ansari, Javed Ali

DOI:         Access: Open Access Read More

Author(s): G. Krishnamoorthy, C. Diana Priyadarshini, R. Senthamarai

DOI:         Access: Open Access Read More

Author(s): Shobha Rani G, Lohita M, Jaya Preethi P, Madhavi R, Sunisitha B, Mounika D

DOI:         Access: Open Access Read More

Author(s): Yogita R. Indalkar, Aloorkar N.H.

DOI: 10.5958/2231-5675.2015.00028.9         Access: Open Access Read More

Author(s): Sushil D. Patil, Sayali K. Chaure, Maswood Ahmed Hafizur Rahman, Prajkta U. Varpe, Sanjay Kshirsagar.

DOI: 10.5958/2231-5675.2017.00004.7         Access: Open Access Read More

Author(s): Pinaz A. Kasad, K.S. Muralikrishna

DOI:         Access: Open Access Read More

Author(s): Kirthi A, Shanmugam R, Mohana Lakshmi S , Ashok Kumar CK, Padmini K, Shanti Prathyusha M, Shilpa V

DOI:         Access: Open Access Read More

Author(s): Mansi J. Chaudhari, Suraj R. Chaudhari, Shailesh S. Chalikwar, Atul A. Shirkhedkar

DOI: 10.5958/2231-5675.2018.00008.X         Access: Open Access Read More

Asian Journal of Pharmaceutical Analysis (AJPA) is an international, peer-reviewed journal, devoted to pharmaceutical analysis...... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5675 


Recent Articles




Tags